Tag: ulcerative colitis

November 7, 2018

Study Shows Biomerica’s Product-led Diet is Successful

Biomerica says specialized diets were created for each patient using the company’s enzyme-linked immunosorbent assay.
November 7, 2018

Biomerica’s Diagnostic Product Guides Exclusionary Diet Treatment to Successfully Alleviate Symptoms of Ulcerative Colitis

Biomerica (Nasdaq:BMRA) is pleased to announce that its first generation food intolerance product has been shown to alleviate symptoms of...
January 30, 2018

Innovate Biopharmaceuticals Announces Successful Merger Completion

Innovate Biopharmaceuticals (Nasdaq:INNT) a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced the completion of its...
January 16, 2018

Phivida Launches Nano-CBD™ Iced Tea Product Line

Phivida's Nano-CBD™ Iced Tea blends are designed to treat the GI-tract, and maximize the body's ability to absorb orally ingested...
February 28, 2017

Lilly to Present New Data for Taltz (ixekizumab)

At the 75th annual meeting of the American Academy of Dermatology (AAD), Lilly (NYSE:LLY) will share new data on its...
February 17, 2017

Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Perianal Fistulas in Crohn's Disease Patients with Cx601

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and Nasdaq: TIG)  (“TiGenix”) today announced new data...
February 17, 2017

Immune Pharmaceuticals Announces the launch of REMAIN ™ , an international Overall Survival study with Ceplene® and low dose Proleukin® in REmission MAINtenance in Acute Myeloid Leukemia

Immune Pharmaceuticals Inc. (Nasdaq: IMNP), will announce on Monday, February 20th, 2017 at the Acute Leukemia XVI symposium in Munich,...